This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Microsoft, UK government sign 5-year deal as tech giant launches Copilot AI agents

By Frank Hersey ( October 21, 2024, 14:54 GMT | Insight) -- Microsoft and the UK government have signed a five-year agreement designed to enable cheaper take-up of Microsoft services across the public sector, including for the first time the artificial intelligence features known collectively as Copilot. The tech giant also launched autonomous agents within the Copilot platform which the likes of Clifford Chance and McKinsey and Company have been piloting.The UK public sector is being incentivized to adopt Microsoft products, including its Copilot functions for the first time. Microsoft CEO Sataya Nadella expects public sector use of its software could prove what he considers the most impactful deployment of its AI tools. Copilot users will be able to create agents via writing rules in natural language, the tech giant announced in a major launch in London today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login